Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Wegner C, Stadelmann C, Pförtner R, Raymond E, Feigelson S, Alon R, Timan B, Hayardeny L, Brück W
J Neuroimmunol. 2010 Oct 8; 227(1-2):133-43. Epub 2010 Aug 03. PMID: 20684995.Abstract